83 related articles for article (PubMed ID: 19852204)
1. Regulation of monocyte chemoattractant protein 1 by cysteinyl leukotriene D4 in human lung epithelial A549 cells.
Kim SH; Yang EM; Kim SH; Park HS
Ann Allergy Asthma Immunol; 2009 Oct; 103(4):358-9. PubMed ID: 19852204
[No Abstract] [Full Text] [Related]
2. Agonist- and T(H)2 cytokine-induced up-regulation of cysteinyl leukotriene receptor messenger RNA in human monocytes.
Shirasaki H; Seki N; Fujita M; Kikuchi M; Kanaizumi E; Watanabe K; Himi T
Ann Allergy Asthma Immunol; 2007 Oct; 99(4):340-7. PubMed ID: 17941281
[TBL] [Abstract][Full Text] [Related]
3. Leukotriene D(4) enhances the function of endothelin-1-primed fibroblasts.
Tokuriki S; Ohshima Y; Yamada A; Ohta N; Tsukahara H; Mayumi M
Clin Immunol; 2007 Oct; 125(1):88-94. PubMed ID: 17627891
[TBL] [Abstract][Full Text] [Related]
4. Cysteinyl leukotrienes induce monocyte chemoattractant protein-1 in human monocyte/macrophages via mitogen-activated protein kinase and nuclear factor-kappaB pathways.
Hashimoto K; Ichiyama T; Hasegawa M; Hasegawa S; Matsubara T; Furukawa S
Int Arch Allergy Immunol; 2009; 149(3):275-82. PubMed ID: 19218821
[TBL] [Abstract][Full Text] [Related]
5. Functional characterisation of receptors for cysteinyl leukotrienes in smooth muscle.
Jonsson EW
Acta Physiol Scand Suppl; 1998 Mar; 641():1-55. PubMed ID: 9597121
[TBL] [Abstract][Full Text] [Related]
6. Induction of monocyte chemoattractant protein-1 release from A549 cells by agonists of protease-activated receptor-1 and -2.
Wang H; Yi T; Zheng Y; He S
Eur J Cell Biol; 2007 Apr; 86(4):233-42. PubMed ID: 17280738
[TBL] [Abstract][Full Text] [Related]
7. Leukotriene D
Al-Azzam N; Elsalem L
Life Sci; 2020 Nov; 260():118452. PubMed ID: 32956660
[TBL] [Abstract][Full Text] [Related]
8. Leukotriene D4 and interleukin-13 cooperate to increase the release of eotaxin-3 by airway epithelial cells.
Provost V; Langlois A; Chouinard F; Rola-Pleszczynski M; Chakir J; Flamand N; Laviolette M
PLoS One; 2012; 7(8):e43544. PubMed ID: 22952702
[TBL] [Abstract][Full Text] [Related]
9. IL-10 inhibits cysteinyl leukotriene-induced activation of human monocytes and monocyte-derived dendritic cells.
Woszczek G; Chen LY; Nagineni S; Shelhamer JH
J Immunol; 2008 Jun; 180(11):7597-603. PubMed ID: 18490762
[TBL] [Abstract][Full Text] [Related]
10. Cysteinyl leukotriene receptor antagonist MK-571 alters bronchoalveolar lavage fluid proteome in a mouse asthma model.
Wong WS; Zhu H; Liao W
Eur J Pharmacol; 2007 Dec; 575(1-3):134-41. PubMed ID: 17689528
[TBL] [Abstract][Full Text] [Related]
11. Inhaled montelukast inhibits cysteinyl-leukotriene-induced bronchoconstriction in ovalbumin-sensitized guinea-pigs: the potential as a new asthma medication.
Muraki M; Imbe S; Sato R; Ikeda Y; Yamagata S; Iwanaga T; Tohda Y
Int Immunopharmacol; 2009 Oct; 9(11):1337-41. PubMed ID: 19706339
[TBL] [Abstract][Full Text] [Related]
12. Comparison study between the mechanisms of allergic asthma amelioration by a cysteinyl-leukotriene type 1 receptor antagonist montelukast and methylprednisolone.
Murai A; Abe M; Hayashi Y; Sakata N; Katsuragi T; Tanaka K
J Pharmacol Exp Ther; 2005 Feb; 312(2):432-40. PubMed ID: 15470084
[TBL] [Abstract][Full Text] [Related]
13. Cysteinyl-leukotriene receptor type 1 expression and function is down-regulated during monocyte-derived dendritic cell maturation with zymosan: involvement of IL-10 and prostaglandins.
Thivierge M; Stankova J; Rola-Pleszczynski M
J Immunol; 2009 Nov; 183(10):6778-87. PubMed ID: 19846883
[TBL] [Abstract][Full Text] [Related]
14. Cysteinyl-leukotrienes in the regulation of beta2-adrenoceptor function: an in vitro model of asthma.
Rovati GE; Baroffio M; Citro S; Brichetto L; Ravasi S; Milanese M; Crimi E; Brusasco V
Respir Res; 2006 Jul; 7(1):103. PubMed ID: 16875498
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of leukotriene receptor antagonists and synthesis inhibitors in asthma.
O'Byrne PM; Gauvreau GM; Murphy DM
J Allergy Clin Immunol; 2009 Sep; 124(3):397-403. PubMed ID: 19608262
[TBL] [Abstract][Full Text] [Related]
16. Cysteinyl-leukotrienes in asthmatic airway smooth muscle cell hyperplasia.
Bossé Y; Stankova J; Rola-Pleszczynski M
Ann Allergy Asthma Immunol; 2009 Jan; 102(1):16-21. PubMed ID: 19205280
[TBL] [Abstract][Full Text] [Related]
17. Characterization of specific binding sites for cysteinyl leukotrienes in sheep lung.
Metters KM; Gareau Y; Lord A; Rochette C; Sawyer N
J Pharmacol Exp Ther; 1994 Jul; 270(1):399-406. PubMed ID: 8035338
[TBL] [Abstract][Full Text] [Related]
18. Cysteinyl-leukotrienes contribute to sputum eosinophil chemotactic activity in asthmatics.
Hemelaers L; Henket M; Sele J; Bureau F; Louis R
Allergy; 2006 Jan; 61(1):136-9. PubMed ID: 16364169
[TBL] [Abstract][Full Text] [Related]
19. The G protein-coupled receptor CysLT1 mediates chemokine-like effects and prolongs survival in chronic lymphocytic leukemia.
Drost AC; Seitz G; Boehmler A; Funk M; Norz KP; Zipfel A; Xue X; Kanz L; Möhle R
Leuk Lymphoma; 2012 Apr; 53(4):665-73. PubMed ID: 21936770
[TBL] [Abstract][Full Text] [Related]
20. Apoptosis signal-regulating kinase 1 in leukotriene D(4)-induced activator protein-1 activation in airway smooth muscle cells.
Kumasawa F; Hashimoto S; Onose A; Jibiki I; Mizumura K; Matsumoto K; Maruoka S; Gon Y; Kobayashi T; Takahashi N; Ichijo H; Horie T
Eur J Pharmacol; 2005 Jul; 517(1-2):11-6. PubMed ID: 15970283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
